정책동향
Ethical Governance of Biological and Biomedical Research: Chinese-European Co-operation
- 등록일2010-01-27
- 조회수7696
- 분류정책동향 > 기타 > 기타
-
자료발간일
2009-12-13
-
출처
http://www.bionet-china.org
-
원문링크
-
키워드
#BIONET 프로젝트
- 첨부파일
Ethical Governance of Biological and Biomedical Research:
Chinese-European Co-operation
Introduction
Ole Döring
The topic of “biobanks” was the focus of the fourth and last of the BIONET’s workshops (URL: http://www.bionet-china.org/workshops4.htm). However, this is the most dynamic and the youngest of the emerging fields of ethical governance of the life sciences between Europe and China under the BIONET’s scrutiny. Infrastructures for biomedical sciences, governance frameworks, ethical issues and awareness of the relevant social and cultural concerns are now taking shape, and there is no internationally established model to implement and follow. Therefore, discussion of “biobanks” offers fascinating opportunities to study these processes while they are being developed. Just a few months after the BIONET’s final workshop in Shenzhen, in October 2009, the eminent Chinese Journal Yixue yu zhexue (Medicine and Philosophy, Vol. 30. no. 10, 2009) published a special issue dedicated to related topics, including several papers that had been presented at this event.
This is a unique situation, when compared with other debates in biomedical ethics. For example, the discussions on Ethical, Legal and Social Issues (ELSI) related to the Human Genome Project that have been going on since 1988 could only respond to the new scientific and institutional facts ex post, but could not anticipate the unfolding potential of the life sciences with their impact on societies. Questions around the governance of biobanking thus reflect a transitional state on a more general level; they come at a time when the related global economies are in flux, when China continues its course of transformation and the capacities of Sino-European collaboration are still contemplated on the agenda of planners and policy makers
.......(계속)
☞ 자세한 내용은 첨부파일을 참고하시기 바랍니다.